Cargando…
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy...
Autores principales: | Isidro, Maria Luisa, Cordido, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991023/ https://www.ncbi.nlm.nih.gov/pubmed/27713245 http://dx.doi.org/10.3390/ph3010125 |
Ejemplares similares
-
Ciprofloxacin Use in Hospitalized Children: Approved or Off-label?
por: Faghihi, Toktam, et al.
Publicado: (2017) -
The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
por: Yunusa, Ismaeel, et al.
Publicado: (2020) -
Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity
por: Gundling, F., et al.
Publicado: (2018) -
Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022) -
Biomedicines—Moving Biologic Agents into Approved Treatment Options
por: Cornetta, Kenneth
Publicado: (2013)